IL-33/ST2 Pathway as a Rational Therapeutic Target for CNS Diseases.

Du, Li-Xia; Wang, Yan-Qing; Hua, Guo-Qiang; Mi, Wen-Li

Du, Li-Xia; Wang, Yan-Qing; Hua, Guo-Qiang; Mi, Wen-Li.

Affiliation

Du LX; Department of Integrative Medicine and Neurobiology, Academy of Integrative Medicine, School of Basic Medical Sciences, Institutes of Brain Science, Brain Science Collaborative Innovation Center, State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai 200032, People's Republic of Ch
Wang YQ; Department of Integrative Medicine and Neurobiology, Academy of Integrative Medicine, School of Basic Medical Sciences, Institutes of Brain Science, Brain Science Collaborative Innovation Center, State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai 200032, People's Republic of Ch
Hua GQ; Institute of Radiation Medicine, Fudan University, Shanghai 200032, People's Republic of China.
Mi WL; Department of Integrative Medicine and Neurobiology, Academy of Integrative Medicine, School of Basic Medical Sciences, Institutes of Brain Science, Brain Science Collaborative Innovation Center, State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai 200032, People's Republic of Ch

Neuroscience ; 369: 222-230, 2018 01 15.

Article in En | MEDLINE | ID: mdl-29175156

Subject(s)

Central Nervous System Diseases/metabolism; Central Nervous System Diseases/therapy; Interleukin-1 Receptor-Like 1 Protein/metabolism; Interleukin-33/metabolism; Animals; Humans; Signal Transduction

Key words

ST2; central nervous system diseases; interleukin-33; signaling

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Central Nervous System Diseases / Interleukin-33 / Interleukin-1 Receptor-Like 1 Protein Limits: Animals / Humans Language: En Journal: Neuroscience Year: 2018 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google